Survey of HFE Gene C282Y Mutation in Turkish Beta-Thalassemia Patients and Healthy Population: A Preliminary Study

OBJECTIVE: This study was planned in order to determine the effect of C282Y mutation in development of secondary hemochromatosis in beta-thalassemia patients and to determine the prevalence and allele frequency of this mutation in a healthy control group. METHODS: Eighty-seven children and young adu...

Full description

Bibliographic Details
Main Authors: Selma Ünal, Günay Balta, Fatma Gümrük
Format: Article
Language:English
Published: Galenos Publishing House 2014-08-01
Series:Turkish Journal of Hematology
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-95776
_version_ 1797916736407732224
author Selma Ünal
Günay Balta
Fatma Gümrük
author_facet Selma Ünal
Günay Balta
Fatma Gümrük
author_sort Selma Ünal
collection DOAJ
description OBJECTIVE: This study was planned in order to determine the effect of C282Y mutation in development of secondary hemochromatosis in beta-thalassemia patients and to determine the prevalence and allele frequency of this mutation in a healthy control group. METHODS: Eighty-seven children and young adults (46 males and 41 females; mean age: 15.6+-6.1 years, range: 3-30 years) with beta-thalassemia major (BTM) and 13 beta-thalassemia intermedia (BTI) patients (6 males and 7 females; mean age: 19.6+-3.5 years, range: 13-26 years) were included in the study. The control group comprised 100 healthy blood donors. RESULTS: Neither heterozygous nor homozygous HFE gene C282Y mutation was detected in patients with BTM or BTI, or in control group. CONCLUSION: The C282Y mutation, which is supposed to be responsible for the majority of hereditary hemochromatosis, was not found to have a role in the development of hemochromatosis in beta-thalassemia patients and was not detected in a healthy Turkish population. However, research on larger cohorts of individuals is required in order to determine the exact prevalence of the HFE gene mutation in Turkish populations from diverse ethnic origins and whether it would have an impact on iron loading in thalassemic populations.
first_indexed 2024-04-10T13:03:04Z
format Article
id doaj.art-bf0f5ec1790e4084b274c2c5c1d303c8
institution Directory Open Access Journal
issn 1308-5263
language English
last_indexed 2024-04-10T13:03:04Z
publishDate 2014-08-01
publisher Galenos Publishing House
record_format Article
series Turkish Journal of Hematology
spelling doaj.art-bf0f5ec1790e4084b274c2c5c1d303c82023-02-15T16:13:06ZengGalenos Publishing HouseTurkish Journal of Hematology1308-52632014-08-0131327227510.4274/Tjh.2012.0081TJH-95776Survey of HFE Gene C282Y Mutation in Turkish Beta-Thalassemia Patients and Healthy Population: A Preliminary StudySelma Ünal0Günay Balta1Fatma Gümrük2Mersin University Faculty Of Medicine, Department Of Pediatric Hematology, Mersin, TurkeyHacettepe University Faculty Of Medicine, Department Of Pediatric Hematology, Ankara, TurkeyHacettepe University Faculty Of Medicine, Department Of Pediatric Hematology, Ankara, TurkeyOBJECTIVE: This study was planned in order to determine the effect of C282Y mutation in development of secondary hemochromatosis in beta-thalassemia patients and to determine the prevalence and allele frequency of this mutation in a healthy control group. METHODS: Eighty-seven children and young adults (46 males and 41 females; mean age: 15.6+-6.1 years, range: 3-30 years) with beta-thalassemia major (BTM) and 13 beta-thalassemia intermedia (BTI) patients (6 males and 7 females; mean age: 19.6+-3.5 years, range: 13-26 years) were included in the study. The control group comprised 100 healthy blood donors. RESULTS: Neither heterozygous nor homozygous HFE gene C282Y mutation was detected in patients with BTM or BTI, or in control group. CONCLUSION: The C282Y mutation, which is supposed to be responsible for the majority of hereditary hemochromatosis, was not found to have a role in the development of hemochromatosis in beta-thalassemia patients and was not detected in a healthy Turkish population. However, research on larger cohorts of individuals is required in order to determine the exact prevalence of the HFE gene mutation in Turkish populations from diverse ethnic origins and whether it would have an impact on iron loading in thalassemic populations.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-95776beta-thalassemiac282y mutationhemochromatosis
spellingShingle Selma Ünal
Günay Balta
Fatma Gümrük
Survey of HFE Gene C282Y Mutation in Turkish Beta-Thalassemia Patients and Healthy Population: A Preliminary Study
Turkish Journal of Hematology
beta-thalassemia
c282y mutation
hemochromatosis
title Survey of HFE Gene C282Y Mutation in Turkish Beta-Thalassemia Patients and Healthy Population: A Preliminary Study
title_full Survey of HFE Gene C282Y Mutation in Turkish Beta-Thalassemia Patients and Healthy Population: A Preliminary Study
title_fullStr Survey of HFE Gene C282Y Mutation in Turkish Beta-Thalassemia Patients and Healthy Population: A Preliminary Study
title_full_unstemmed Survey of HFE Gene C282Y Mutation in Turkish Beta-Thalassemia Patients and Healthy Population: A Preliminary Study
title_short Survey of HFE Gene C282Y Mutation in Turkish Beta-Thalassemia Patients and Healthy Population: A Preliminary Study
title_sort survey of hfe gene c282y mutation in turkish beta thalassemia patients and healthy population a preliminary study
topic beta-thalassemia
c282y mutation
hemochromatosis
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-95776
work_keys_str_mv AT selmaunal surveyofhfegenec282ymutationinturkishbetathalassemiapatientsandhealthypopulationapreliminarystudy
AT gunaybalta surveyofhfegenec282ymutationinturkishbetathalassemiapatientsandhealthypopulationapreliminarystudy
AT fatmagumruk surveyofhfegenec282ymutationinturkishbetathalassemiapatientsandhealthypopulationapreliminarystudy